ESPE Abstracts (2021) 94 P2-2

ESPE2021 ePoster Category 2 Adrenals and HPA Axis (57 abstracts)

How do urine steroid metabolites of spot samples correlate with 24 hour urine specimens in children with congenital adrenal hyperplasia?

Grit Sommer 1,2 , Ozair Abawi 3 , Michael Groessl 4 , Ulrike Halbsguth 1 , Evangelia Charmandari 5,6 , Erika L.T. van den Akker 3 & Christa E. Flück 1,2


1Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; 2Department for BioMedical Research, University of Bern, Bern, Switzerland; 3Department of Pediatrics, Division of Endocrinology, Erasmus MC-Sophia, University Medical Center, Rotterdam, Netherlands; 4Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; 5Division of Endocrinology, Metabolism and Diabetes, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, Athens, Greece; 6Division of Endocrinology and Metabolism, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece


Introduction: Steroid profiling in children with congenital adrenal hyperplasia (CAH) is used to monitor the balance between androgen and cortisol metabolites and to decide on the optimal glucocorticoid dosage. Twenty-four hour collection is the gold standard for measurement of steroid metabolites in urine, because steroid production follows a circadian rhythm and is influenced by short-term stress and steroid drugs. For some children, e.g. those who were diapers, it is not feasible to collect urine over 24h non-invasively, and urine spot steroid assessments might still be an alternative in CAH.

Objective: To investigate whether steroid metabolites in 24h urine collections correlate with those determined in urine spot samples in children with CAH.

Methods: We collected 24h urine and urine spots from children and adolescents with CAH due to 21-hydroxylase deficiency and analysed 40 steroid metabolites using GC-MS (see Table). To assess the strength of correlations between 24h and spot urine metabolites, we calculated Kendall’s tau-beta separate for morning and non-morning urine. We set the level to α=0.005 to account for multiple testing.

Results: Thirty patients provided both 24h collections and spot urine samples (n = 20 morning, n = 10 non-morning). Out of the 40 metabolites, there was a strong correlation between 24h and morning spot urine for 17 metabolites, and between 24h and non-morning spot urine for 9 metabolites (tau>0.45, P < 0.005). Specifically, correlations were noted for progesterones, corticosterones, tetrahydroaldosterone, androgens, estriol, tetrahydro-11-deoxycortisol, but not for the cortisol metabolites (Table).

Table Correlations between 24h and spot urine metabolites in children with CAH.
24h vs morning n = 2024h vs non-morning n = 10
Progesterones
17-hydroxypregnanolone++
Pregnanediol+
Pregnanetriol++
11-oxo-pregnanetriol++
Corticosterones
TH-deoxycorticosterone+
TH-11-DH-corticosterone
TH-corticosterone+
5α-TH-corticosterone++
TH-Aldosterone+
Androgens
Androsterone++
Etiocholanolone + +
Dihydroandrosterone + +
11-oxo-etiocholanolone
11β-OH-androsterone++
11β-OH-etiocholanolone+
Dehydroepiandrosterone+
Androstenediol
16α-OH-DHEA
Androstenetriol
Pregnenetriol+
Testosterone
5α-dihydrotestosterone
Estrogens
Estriol +
17β-estradiol
TH-11-deoxycortisol + +
Cortisols
Cortisone
TH-cortisone
β-cortolone
20α-dihydrocortisone
20β-dihydrocortisone
Cortisol
TH-cortisol
5α-TH-cortisol
α-cortole
β-cortole
20α-dihydrocortisol
20β-dihydrocortisol
6β-OH-cortisol
18-OH-cortisol
α-cortolone
Legend: +, strong correlation (Kendall’s tau >0.45 and P < 0.005); empty cells, correlation not significant.

Conclusions: Urinary steroid profiling in children with CAH revealed correlations between 24h urine specimens and spot urines. Spot urine might suffice to recognize the specific pattern of 21-hydroxylase deficiency for diagnostics (e.g. through marker metabolites 11-oxo-pregnanetriol, TH-11-deoxycortisol). Whether a spot urine can inform about metabolic control of treatment in CAH needs to be further tested in a larger number of specimens.

Volume 94

59th Annual ESPE (ESPE 2021 Online)

Online,
22 Sep 2021 - 26 Sep 2021

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

lin hu (<1 min ago)
N Pons (<1 min ago)
Owen K (<1 min ago)
Yan Yi (<1 min ago)
zhe Su (<1 min ago)